SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)

[NEWS RELEASEystar Bio-Pharmaceutical to Present at Rodman & Renshaw XIAN, CHINA September 1 , 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), announced that thempany will present at theystar@grayling.com Thenference willlude a series of one-on-one meetings with institutional investors.Investors interested inheduling a meeting with Mr. Weibing Lu and the management teamn facilitate a request]

By | 2016-02-05T04:01:16+00:00 September 1st, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: NEWS RELEASEystar Bio-Pharmaceutical to Present at Rodman &

[NEWS RELEASEystar Bio-Pharmaceutical to Present at Rodman & Renshaw XIAN, CHINA September 1 , 2010 -- -ystar Bio-Pharmaceuticalmpany (NASDAQ:SKBI) ("Skystar" or the "Company"), announced that thempany will present at theystar@grayling.com Thenference willlude a series of one-on-one meetings with institutional investors.Investors interested inheduling a meeting with Mr. Weibing Lu and the management teamn facilitate a request]

By | 2016-02-05T04:01:51+00:00 September 1st, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] CORRESP: (Original Filing)

[Skystar Bio-Pharmaceutical Company Room 10601, Jiezuo Plaza, No. 4, Fenghui Road South Gaoxin District, Xi’an, Shaanxi Province People’s Republic of China Tel: (8629) 8819-3188 August 18, 2010 FILED AS EDGAR CORRESPONDENCE Division of Corporation Finance 450 Fifth Street, N.W. Attn: Tabatha Akins, Division of Corporation Finance Re: Skystar Bio-Pharmaceutical Company Comment Letter Dated July 9, 2010 Dear Ms. Akins: Set]

By | 2016-03-01T05:50:11+00:00 August 18th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] CORRESP: Skystar Bio-Pharmaceutical Company Room 10601, Jiezuo Plaza, No.

[Skystar Bio-Pharmaceutical Company Room 10601, Jiezuo Plaza, No. 4, Fenghui Road South Gaoxin District, Xi’an, Shaanxi Province People’s Republic of China Tel: (8629) 8819-3188 August 18, 2010 FILED AS EDGAR CORRESPONDENCE Division of Corporation Finance 450 Fifth Street, N.W. Attn: Tabatha Akins, Division of Corporation Finance Re: Skystar Bio-Pharmaceutical Company Comment Letter Dated July 9, 2010 Dear Ms. Akins: Set]

By | 2016-03-01T05:51:25+00:00 August 18th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] CORRESP: (Original Filing)

[Skystar Bio-Pharmaceuticalmpany Room 10601, Jiezuo Plaza, No. 4, Fenghui Road South Gaoxin District, Xian, Shaanxi Province Peoples Republic of China Tel: (8629) 8819-3188 August 18, 2010 FILED EDGARRRESPONDENCE Division ofrporation Finance 450 Fifth Street, N.W. Attn: Tabatha Akins, Division ofrporation Finance Re:ystar Bio-Pharmaceuticalmpanymment Letterted July 9, 2010]

By | 2016-02-05T04:02:45+00:00 August 18th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] CORRESP: Skystar Bio-Pharmaceuticalmpany Room 10601, Jiezuo Plaza, No. 4,

[Skystar Bio-Pharmaceuticalmpany Room 10601, Jiezuo Plaza, No. 4, Fenghui Road South Gaoxin District, Xian, Shaanxi Province Peoples Republic of China Tel: (8629) 8819-3188 August 18, 2010 FILED EDGARRRESPONDENCE Division ofrporation Finance 450 Fifth Street, N.W. Attn: Tabatha Akins, Division ofrporation Finance Re:ystar Bio-Pharmaceuticalmpanymment Letterted July 9, 2010]

By | 2016-02-05T04:03:39+00:00 August 18th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenue increased 46.4% to $19.4 million - Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income]

By | 2016-03-03T14:09:01+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4%

[BIOSTAR PHARMACEUTICALS, INC. SECOND QUARTER REVENUE INCREASED 46.4% TO $19.4 MILLION XIANYANG, China, August 17, 2010 - Q2 2010 revenue increased 46.4% to $19.4 million - Q2 2010 Non-GAAP adjusted net income increased 50.9% to $5.8 million with adjusted EPS of $0.21 - Biostar reiterates guidance for 2010: Revenue expected to be between $80.0 to $82.0 million and net income]

By | 2016-03-03T14:10:24+00:00 August 17th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar